Introduction:
In a significant judgment balancing statutory regulation with reproductive autonomy, the Delhi High Court has held that the Assisted Reproductive Technology (Regulation) Act, 2021, should not be interpreted in a manner that creates unreasonable barriers for couples who have already lawfully commenced fertility treatment. The Court observed that while the Act prescribes age-based eligibility criteria for availing assisted reproductive technology (ART) procedures, its provisions must be applied in a manner consistent with constitutional values, individual dignity, reproductive choice, and decisional autonomy.
The ruling was delivered by Justice Purushaindra Kumar Kaurav in the case of Shewta Tuteja & Another v. Union of India & Others. The case arose from a petition filed by a married couple seeking permission to undergo Frozen Embryo Transfer (FET) using embryos that had been cryopreserved during an earlier stage of fertility treatment. The controversy emerged because, by the time the couple sought implantation of the remaining embryos, the woman had crossed the upper age limit prescribed under Section 21(g) of the Assisted Reproductive Technology (Regulation) Act, 2021.
The ART Act was enacted to regulate assisted reproductive procedures and ensure ethical standards, transparency, and accountability in fertility treatment. Among its various provisions, Section 21 prescribes age limits for intending beneficiaries seeking ART services. The legislation aims to safeguard the health of individuals undergoing treatment while ensuring that fertility clinics and ART banks operate within a structured legal framework.
The petitioners had initially undergone fertility treatment when they were fully eligible under the statutory age requirements. During the course of that treatment, embryos were successfully created and cryopreserved under medical supervision. However, after several attempts and the passage of time, five embryos remained preserved. When the petitioners sought permission to use these embryos through frozen embryo transfer, authorities raised objections on the ground that the woman had crossed the upper age threshold prescribed by law.
The petitioners contended that they were not seeking a fresh ART cycle, nor were they requesting the creation of new embryos after crossing the statutory age limit. Instead, they merely sought continuation of an already initiated reproductive process involving embryos that had been lawfully created while they satisfied all legal requirements.
The case therefore raised an important question at the intersection of reproductive rights and statutory regulation: whether a couple who lawfully created and preserved embryos within the permissible age limits could subsequently be denied the opportunity to use those embryos solely because they crossed the statutory age threshold during the continuation of treatment.
The matter also invited judicial consideration of broader constitutional principles concerning reproductive autonomy, privacy, dignity, and the right to make intimate decisions relating to family life and parenthood. The Court was called upon to determine whether the objective of the ART Act would be served by a rigid interpretation of age restrictions or whether a purposive interpretation was necessary to protect legitimate reproductive interests.
Arguments of the Parties:
The petitioners argued that the refusal to permit utilization of the remaining cryopreserved embryos was contrary to both the spirit of the ART Act and the constitutional protections available to reproductive choice. They submitted that the treatment process had commenced when they fully satisfied all statutory requirements, including the prescribed age criteria.
According to the petitioners, the embryos in question were not newly created after crossing the statutory age threshold. Rather, they were embryos that had been retrieved, fertilized, and cryopreserved at a time when the woman undisputedly fell within the permissible age limit prescribed under the law.
The petitioners emphasized that they were not seeking initiation of a fresh assisted reproductive technology cycle. No fresh ovarian stimulation, retrieval of eggs, fertilization, or embryo creation was being requested. Their request was confined to implantation of embryos already in existence and lawfully preserved through a process that had commenced under medical supervision and statutory compliance.
It was further argued that denial of permission would effectively render the preserved embryos unusable and frustrate the very purpose for which they had been created and stored. Such an outcome, according to the petitioners, would disproportionately interfere with their reproductive autonomy and constitutional right to make decisions relating to parenthood and family formation.
The petitioners also relied upon evolving constitutional jurisprudence recognizing reproductive choice as an integral component of personal liberty, dignity, privacy, and bodily autonomy under Article 21 of the Constitution. They contended that statutory provisions regulating fertility treatment must be interpreted harmoniously with these constitutional guarantees.
On the other hand, the respondents, including the Union of India and regulatory authorities, relied upon the age restrictions contained in the Assisted Reproductive Technology (Regulation) Act, 2021. It was contended that Parliament had consciously prescribed age-based eligibility criteria to ensure medical safety and to regulate access to assisted reproductive technologies.
The respondents argued that the statutory framework must be respected and that permitting treatment after crossing the prescribed age limit could potentially dilute the regulatory scheme established by the legislature.
It was submitted that age restrictions are not arbitrary conditions but form part of a carefully designed regulatory mechanism intended to balance reproductive aspirations with health considerations and ethical concerns. Therefore, authorities were bound by the statute while considering requests for ART procedures.
At the same time, the respondents acknowledged the factual distinction involved in the present case, namely that the embryos had already been created and preserved before the petitioners crossed the age threshold. The Court was therefore required to examine whether continuation of an already initiated treatment process could be treated differently from commencement of a fresh reproductive cycle.
The competing submissions ultimately required the Court to determine the proper interpretation of the ART Act in situations where the statutory age limit is crossed after lawful creation and preservation of embryos.
Court’s Judgment:
Justice Purushaindra Kumar Kaurav delivered a nuanced judgment that carefully balanced statutory regulation with constitutional protections relating to reproductive autonomy.
At the outset, the Court observed that the Assisted Reproductive Technology (Regulation) Act, 2021, is fundamentally regulatory in character. Its primary purpose is to establish safeguards, maintain ethical standards, and regulate the functioning of fertility clinics and ART procedures. The Court noted that the Act was not enacted to create insurmountable barriers that defeat legitimate treatment processes already lawfully undertaken.
The Court emphasized that statutory interpretation cannot be divorced from the factual realities of individual cases. Where the application of a provision leads to consequences that undermine the very objectives of the legislation or disproportionately interfere with constitutional rights, courts must adopt a purposive and contextual approach.
A central aspect of the Court’s reasoning was the distinction between initiation of a fresh ART cycle and continuation of an already commenced treatment process.
Justice Kaurav held that the present case did not involve commencement of a new fertility treatment after the statutory age limit had been crossed. The petitioners were not seeking creation of fresh embryos, retrieval of additional reproductive material, or initiation of a new assisted reproductive cycle. Instead, they sought utilization of embryos that had already been lawfully created and cryopreserved during a period when they fully complied with the statutory eligibility criteria.
The Court observed that this distinction was crucial because the regulatory concerns underlying age restrictions are significantly different in cases involving fresh treatment compared to those involving continuation of an existing reproductive process.
The judgment noted that the woman was presently stated to be approximately 50 years and 2 months old, while her husband was stated to be 54 years old. However, the embryos sought to be utilized had come into existence during the subsistence of the permissible statutory age and pursuant to treatment undertaken under proper medical supervision.
The Court categorically rejected an interpretation that would treat the crossing of the age threshold as an automatic and absolute bar in such circumstances.
Justice Kaurav observed that reproductive rights and access to parenthood occupy an important place in contemporary constitutional jurisprudence. The Court stated that such rights cannot be reduced to a purely technical or pedantic application of statutory provisions detached from the factual context in which they arise.
The judgment drew attention to the constitutional values of dignity, privacy, autonomy, and decisional freedom. The Court recognized that decisions relating to procreation and family life constitute deeply personal matters deserving constitutional protection.
According to the Court, the cryopreserved embryos were not merely biological material preserved in storage. Rather, they represented a tangible manifestation of the petitioners’ reproductive choices and aspirations. The embryos were intrinsically connected to their constitutionally protected interests relating to parenthood, family formation, and reproductive autonomy.
The Court therefore concluded that a purposive interpretation of the ART Act was necessary. Such an interpretation would preserve the legislative objective of regulation while simultaneously respecting the constitutional rights implicated in the case.
Justice Kaurav observed that denying permission solely because the petitioners had marginally crossed the statutory age limit after the embryos had already been created would not advance the object of the legislation. Instead, it would defeat the legitimate expectations of individuals who had commenced treatment lawfully and in compliance with all statutory requirements.
The Court emphasized that regulatory statutes should not be interpreted in a manner that produces irrational or unjust outcomes. The purpose of age restrictions is to regulate access to fertility treatment at the stage of initiation. Once treatment has lawfully commenced and embryos have been created, a different set of considerations arises, requiring a more contextual and rights-sensitive approach.
The judgment thus harmonized the provisions of the ART Act with constitutional principles relating to reproductive choice and decisional autonomy.
Consequently, the Court allowed the petition and granted permission to the petitioners to undergo frozen embryo transfer using their remaining five cryopreserved embryos.
However, the Court clarified that the procedure must be conducted with all necessary medical safeguards and in accordance with applicable professional standards.
The ruling is significant because it recognizes that reproductive rights extend beyond the mere initiation of fertility treatment and encompass the legitimate continuation of processes already lawfully undertaken. It underscores the principle that regulatory legislation must be interpreted in a manner that advances, rather than frustrates, constitutional freedoms.
The judgment also contributes to the growing body of Indian jurisprudence recognizing reproductive autonomy as an integral component of the right to life and personal liberty under Article 21. By drawing a distinction between fresh treatment cycles and continuation of existing reproductive processes, the Court has provided important guidance for future cases involving cryopreserved embryos and assisted reproductive technologies.
Ultimately, the decision reaffirms that while statutory regulations serve an essential role in governing fertility treatment, they cannot be applied mechanically in a manner that extinguishes legitimate reproductive choices or undermines constitutionally protected aspirations relating to parenthood and family life.